RNA interference in Schistosoma mansoni schistosomula: selectivity, sensitivity and operation for larger-scale screening.

Publisher: Public Library of Science Country of Publication: United States NLM ID: 101291488 Publication Model: Electronic Cited Medium: Internet ISSN: 1935-2735 (Electronic) Linking ISSN: 19352727 NLM ISO Abbreviation: PLoS Negl Trop Dis Subsets: MEDLINE

Original Publication: San Francisco, CA : Public Library of Science

RNA Interference*; Gene Targeting/*methods ; Helminth Proteins/*antagonists & inhibitors ; Helminth Proteins/*genetics ; Parasitology/*methods ; Schistosoma mansoni/*genetics; Animals ; Schistosoma mansoni/physiology ; Sensitivity and Specificity

Background: The possible emergence of resistance to the only available drug for schistosomiasis spurs drug discovery that has been recently incentivized by the availability of improved transcriptome and genome sequence information. Transient RNAi has emerged as a straightforward and important technique to interrogate that information through decreased or loss of gene function and identify potential drug targets. To date, RNAi studies in schistosome stages infecting humans have focused on single (or up to 3) genes of interest. Therefore, in the context of standardizing larger RNAi screens, data are limited on the extent of possible off-targeting effects, gene-to-gene variability in RNAi efficiency and the operational capabilities and limits of RNAi.
Methodology/principal Findings: We investigated in vitro the sensitivity and selectivity of RNAi using double-stranded (ds)RNA (approximately 500 bp) designed to target 11 Schistosoma mansoni genes that are expressed in different tissues; the gut, tegument and otherwise. Among the genes investigated were 5 that had been previously predicted to be essential for parasite survival. We employed mechanically transformed schistosomula that are relevant to parasitism in humans, amenable to screen automation and easier to obtain in greater numbers than adult parasites. The operational parameters investigated included defined culture media for optimal parasite maintenance, transfection strategy, time- and dose-dependency of RNAi, and dosing limits. Of 7 defined culture media tested, Basch Medium 169 was optimal for parasite maintenance. RNAi was best achieved by co-incubating parasites and dsRNA (standardized to 30 µg/ml for 6 days); electroporation provided no added benefit. RNAi, including interference of more than one transcript, was selective to the gene target(s) within the pools of transcripts representative of each tissue. Concentrations of dsRNA above 90 µg/ml were directly toxic. RNAi efficiency was transcript-dependent (from 40 to >75% knockdown relative to controls) and this may have contributed to the lack of obvious phenotypes observed, even after prolonged incubations of 3 weeks. Within minutes of their mechanical preparation from cercariae, schistosomula accumulated fluorescent macromolecules in the gut indicating that the gut is an important route through which RNAi is expedited in the developing parasite.
Conclusions: Transient RNAi operates gene-selectively in S. mansoni newly transformed schistosomula yet the sensitivity of individual gene targets varies. These findings and the operational parameters defined will facilitate larger RNAi screens.

Expert Opin Drug Discov. 2007 Oct;2(s1):S9-S23. (PMID: 23489037)
J Cell Sci. 2004 Jun 1;117(Pt 13):2631-9. (PMID: 15169834)
PLoS Pathog. 2008 Nov;4(11):e1000201. (PMID: 18989463)
Parasitology. 2008 Feb;135(2):141-53. (PMID: 17991304)
Mol Biochem Parasitol. 2004 Mar;134(1):65-73. (PMID: 14747144)
BMC Genomics. 2008 Jun 26;9:304. (PMID: 18578888)
PLoS Pathog. 2006 Jun;2(6):e54. (PMID: 16789838)
J Parasitol. 1986 Aug;72(4):606-9. (PMID: 3783356)
Drug Discov Today. 2007 Jan;12(1-2):28-33. (PMID: 17198970)
Trop Med Int Health. 2002 Feb;7(2):104-17. (PMID: 11841700)
Exp Parasitol. 2007 Nov;117(3):284-91. (PMID: 17870072)
Methods Mol Biol. 2000;132:365-86. (PMID: 10547847)
PLoS Pathog. 2006 Apr;2(4):e29. (PMID: 16617374)
Curr Opin Microbiol. 2008 Jun;11(3):262-70. (PMID: 18539520)
Exp Parasitol. 2007 Nov;117(3):236-45. (PMID: 17517391)
Biochem Biophys Res Commun. 1981 Jul 30;101(2):454-8. (PMID: 7306089)
Parasitology. 2009 Sep;136(11):1257-67. (PMID: 19646304)
Int J Parasitol. 2003 Apr;33(4):363-9. (PMID: 12705930)
J Biol Chem. 2006 Dec 22;281(51):39316-29. (PMID: 17028179)
Exp Parasitol. 2010 Oct;126(2):146-55. (PMID: 20417203)
BMC Genomics. 2009 Mar 25;10:128. (PMID: 19320991)
PLoS Med. 2007 Jan;4(1):e14. (PMID: 17214506)
Mol Biochem Parasitol. 2007 Jun;153(2):194-202. (PMID: 17420062)
Genome Biol. 2007;8(4):R65. (PMID: 17456242)
PLoS Negl Trop Dis. 2009 Nov 03;3(11):e543. (PMID: 19885392)
Acta Trop. 2002 May;82(2):247-52. (PMID: 12020898)
Nature. 2009 Jul 16;460(7253):345-51. (PMID: 19606140)
PLoS One. 2009;4(2):e4413. (PMID: 19198654)
PLoS Pathog. 2010 Apr 15;6(4):e1000840. (PMID: 20419145)
Nat Biotechnol. 2003 Jun;21(6):635-7. (PMID: 12754523)
Mol Biochem Parasitol. 2005 Oct;143(2):209-15. (PMID: 16076506)
Nat Genet. 2003 Oct;35(2):148-57. (PMID: 12973350)
Mol Biol Evol. 2000 Jul;17(7):1123-5. (PMID: 10889225)
PLoS Med. 2007 Jun;4(6):e206. (PMID: 17579510)
Parasitol Res. 2003 Jun;90 Supp 1:S3-9. (PMID: 12811543)
AIDS. 2006 Feb 28;20(4):593-600. (PMID: 16470124)
Nucleic Acids Res. 2009 Jan;37(Database issue):D579-82. (PMID: 18842636)
FASEB J. 2009 Aug;23(8):2780-9. (PMID: 19364765)
Biochem J. 1996 Apr 1;315 ( Pt 1):85-9. (PMID: 8670136)
PLoS Negl Trop Dis. 2009 Jul 14;3(7):e478. (PMID: 19597541)
Mol Cell Proteomics. 2006 Feb;5(2):347-56. (PMID: 16269422)
Nat Cell Biol. 2005 Jun;7(6):591-600. (PMID: 15864305)
Nat Protoc. 2006;1(3):1559-82. (PMID: 17406449)
Nature. 2004 Sep 16;431(7006):371-8. (PMID: 15372045)
Nature. 2006 Sep 21;443(7109):359-63. (PMID: 16964239)
PLoS Negl Trop Dis. 2009 Jun 02;3(6):e449. (PMID: 19488406)
Parasitol Int. 2009 Mar;58(1):61-8. (PMID: 19007911)
PLoS Med. 2006 Jan;3(5):e102. (PMID: 16435908)
Exp Parasitol. 2007 Nov;117(3):246-58. (PMID: 17577588)
PLoS Med. 2005 Nov;2(11):e336. (PMID: 16212468)
Mol Biochem Parasitol. 2010 Mar;170(1):37-40. (PMID: 19914302)
Parasitology. 2009 Nov;136(13):1859-74. (PMID: 19906318)
Exp Parasitol. 1965 Apr;16:133-47. (PMID: 14281210)
Mol Biochem Parasitol. 2003 May;128(2):205-15. (PMID: 12742587)
Trans R Soc Trop Med Hyg. 1973;67(5):694-701. (PMID: 4779115)
Expert Rev Anti Infect Ther. 2009 Feb;7(1):37-56. (PMID: 19622056)
Lancet. 2009 May 2;373(9674):1570-5. (PMID: 19410718)
RNA. 2006 Jul;12(7):1188-96. (PMID: 16682561)
Exp Parasitol. 2008 Jan;118(1):122-8. (PMID: 17707814)
PLoS Pathog. 2010 Jun 03;6(6):e1000932. (PMID: 20532163)
Methods Mol Biol. 2009;563:275-87. (PMID: 19597791)
PLoS Negl Trop Dis. 2009 May 26;3(5):e430. (PMID: 19479041)
Genome Biol. 2010;11(4):R41. (PMID: 20388197)
Acta Trop. 2008 Nov-Dec;108(2-3):179-82. (PMID: 18554565)
Parasitol Res. 2009 Oct;105(4):899-906. (PMID: 19588166)
PLoS Negl Trop Dis. 2009 Jul 14;3(7):e477. (PMID: 19597543)
Mol Biochem Parasitol. 2009 Mar;164(1):26-31. (PMID: 19041905)
Trends Parasitol. 2006 Jul;22(7):285-91. (PMID: 16730230)
Mol Biochem Parasitol. 2002 Apr 30;121(1):49-61. (PMID: 11985862)
Eur J Cancer Prev. 1995 Feb;4(1):45-59. (PMID: 7728097)
Am J Hyg. 1958 Nov;68(3):322-39. (PMID: 13594932)
PLoS Negl Trop Dis. 2009 Aug 11;3(8):e502. (PMID: 19668375)
Int J Parasitol. 2007 Apr;37(5):465-73. (PMID: 17280677)
Curr Opin Chem Biol. 2007 Aug;11(4):433-9. (PMID: 17652008)
Trends Parasitol. 2004 May;20(5):241-8. (PMID: 15105025)
Parasitology. 2009 Oct;136(12):1593-610. (PMID: 19627633)
Nat Genet. 2003 Oct;35(2):139-47. (PMID: 12973349)
Nucl Recept Signal. 2003;1:e012. (PMID: 16604184)
FEBS Lett. 1991 Mar 25;280(2):307-10. (PMID: 2013328)
Nat Biotechnol. 2004 Dec;22(12):1567-72. (PMID: 15558047)
Exp Parasitol. 1974 Feb;35(1):44-51. (PMID: 4815018)
Mil Med. 2007 Feb;172(2):144-6. (PMID: 17357767)
BMC Genomics. 2010 Mar 15;11:175. (PMID: 20230625)
Lancet. 2006 Sep 23;368(9541):1106-18. (PMID: 16997665)
Clin Microbiol Rev. 2008 Jan;21(1):225-42. (PMID: 18202444)
J Parasitol. 1981 Apr;67(2):179-85. (PMID: 7241277)
Methods. 2001 Dec;25(4):402-8. (PMID: 11846609)
Parasitology. 2010 Mar;137(3):485-95. (PMID: 19765345)
Mol Biochem Parasitol. 2009 Oct;167(2):118-26. (PMID: 19463860)
Nat Rev Drug Discov. 2008 Nov;7(11):900-7. (PMID: 18927591)
Brief Funct Genomic Proteomic. 2005 Jul;4(2):178-85. (PMID: 16102272)
Nat Methods. 2006 Oct;3(10):833-8. (PMID: 16964256)
PLoS Negl Trop Dis. 2009 Aug 25;3(8):e505. (PMID: 19707280)
Nature. 2009 Jul 16;460(7253):352-8. (PMID: 19606141)
Trends Biotechnol. 2005 Sep;23(9):446-8. (PMID: 15979179)
Expert Rev Anti Infect Ther. 2006 Apr;4(2):199-210. (PMID: 16597202)
J Am Chem Soc. 2006 May 3;128(17):5616-7. (PMID: 16637611)
Parasit Vectors. 2008 Mar 18;1(1):7. (PMID: 18348719)
Parasitology. 2009 Nov;136(13):1825-35. (PMID: 19281637)
Int J Parasitol. 2005 Jun;35(7):787-91. (PMID: 15925597)
Nat Rev Genet. 2008 Apr;9(4):303-13. (PMID: 18347593)
Exp Parasitol. 1965 Aug;17(1):15-23. (PMID: 5321011)
PLoS Negl Trop Dis. 2009 Aug 18;3(8):e504. (PMID: 19688043)
Mol Biochem Parasitol. 2008 Feb;157(2):160-8. (PMID: 18067980)
Trends Parasitol. 2006 Jul;22(7):313-21. (PMID: 16713738)

0 (Helminth Proteins)

Date Created: 20101027 Date Completed: 20110124 Latest Revision: 20211020

20231215

PMC2957409

10.1371/journal.pntd.0000850

20976050